AVTX
Avalo TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
AVTX vs peer average
52/100
AVTX vs. peer average (B vs. B)
Grade spread
A 4 · B 2 · C 1 · D 2
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ACRS is the first available peer comparator.
Closest fit in the provided peer set because it is also a small-cap clinical dermatology/immunology biotech where readouts and capital access can drive outsized equity moves.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AVTX
Avalo Therapeutics
ACRS
Aclaris Therapeutics
Grade
B
A
Momentum
77
88
Value
41
41
Sentiment
61
68
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs ACRS
AVTX / ACRS
Grade Position
In line
AVTX vs. peer average (B vs. B)
52/100
Momentum
77
ACRSValue
41
AVTXSentiment
61
ACRSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AVTX
ACRS is the first peer returned for this comparison set.